Capecitabine (Xeloda)

TERMINATED · PHASE1 · Cancer of Liver

lack of accrual

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.